(Q77697197)

English

Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck

scientific article published on 01 April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

based on heuristic

inferred from title

tumor angiogenesis

1 reference

based on heuristic

inferred from title

author name string

Hideaki Katori

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Yuh Baba

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Yukari Imagawa

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Goshi Nishimura

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Yuumi Kagesato

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Emi Takagi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Akiko Ishii

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Shunsuke Yanoma

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Ryuji Maekawa

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Takayuki Yoshioka

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Yoji Nagashima

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Yasumasa Kato

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Mamoru Tsukuda

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

178

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

151-159

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

How does extracellular matrix control capillary morphogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental metastasis is suppressed in MMP-9-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical potential of matrix metalloprotease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ongoing trials with matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The sensitivity of head and neck squamous cell carcinomas to tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Production of trypsins by human gastric cancer cells correlates with their malignant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inostamycin, an inhibitor of cytidine 5'-diphosphate 1,2-diacyl-sn-glycerol (CDP-DG): inositol transferase, suppresses invasion ability by reducing productions of matrix metalloproteinase-2 and -9 and cell motility in HSC-4 tongue carcinoma cell lin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinase inhibitors: present achievements and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Paradoxical stimulation of matrix metalloproteinase-9 expression in HT1080 cells by a broad-spectrum hydroxamate-based matrix metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2801%2900837-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0304-3835(01)00837-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11867199%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77697197&oldid=1758048031"